{"id":"W2083415436","doi":"10.1111/j.1463-1326.2011.01493.x","title":"Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta‐analysis of the liraglutide clinical trial programme","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Novo Nordisk","keywords":"Liraglutide; Medicine; Sitagliptin; Glimepiride; Exenatide; Type 2 diabetes; Internal medicine; Weight loss; Rosiglitazone; Weight gain; Placebo; Diabetes mellitus; Endocrinology; Obesity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0232429,0.003550221,0.01701999,0.003389365,0.0005038626,0.00361724,0.002078816,0.002199483,0.003019416],"category_scores_gemma":[0.02538468,0.001645012,0.05699286,0.003829201,0.000696305,0.001456857,0.001488653,0.002572361,0.0004062871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001842152,"about_ca_system_score_gemma":0.001331441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004458821,"about_ca_topic_score_gemma":0.006863758,"domain_scores_codex":[0.9828064,0.01234004,0.002080733,0.001494946,0.0009250405,0.0003526513],"domain_scores_gemma":[0.98685,0.009192037,0.001930503,0.001051923,0.0006562446,0.0003192938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01348632,0.00002564236,0.002895876,0.0188682,0.9607047,0.00006998431,0.00002922775,0.0009311649,0.0002423385,0.00006337092,0.0003274195,0.002355797],"study_design_scores_gemma":[0.002649859,0.000358979,0.002561385,0.0008438168,0.9924628,0.00004893318,0.00001789216,0.0004492961,0.0001043523,0.000133691,0.0003507325,0.00001832852],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1170943,0.8701115,0.005525732,0.0009396809,0.0008962005,0.001000252,0.002397207,0.0002855846,0.00174939],"genre_scores_gemma":[0.9134458,0.07733901,0.003695389,0.001095543,0.0003866598,0.001126812,0.001747488,0.0001175249,0.001045783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0232429,"threshold_uncertainty_score":0.1229217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1609040643722358,"score_gpt":0.3953648381021613,"score_spread":0.2344607737299255,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}